ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Maintaining Drug Bioavailability And Masking Taste With Microencapsulation

  Several technologies are available for microencapsulating drugs. Finding the right CDMO to optimize a drug’s efficacy and manufacturing during formulation is integral to its clinical and commercial success.

• Propelling Gene Therapies From Lab To Clinic

  Many companies are turning to CDMOs to optimize biomanufacturing processes and address the growing list of complications on the path to commercialization.

• A Smarter Strategy For Optimizing Oncology Drug Products

  John McDermott, VP of Scientific Consulting, shares insights on the benefits of evaluating targeted oncology molecules in healthy volunteers and applying an effective platform to accelerate drug product optimization.

• Advances In Spray Drying For Enhanced Bioavailability And Improved Formulation Control

  In a recent webinar, Lonza discussed the process it uses to develop a spray dried powder formulation and scale from early feasibility studies to manufacturing.

• Taste Masking 101: Optimize Taste And Improve Patient Outcomes

  Taste masking is integral for a drug product’s final formulation. It can serve to increase patient acceptability and adherence to a therapy, in turn bolstering regulatory acceptance and commercial potential.

• Stability Chambers: Testing, Equipment, And Uses

  Performing stability studies is a critical step in the drug development process. Discover the ways to ensure that your drug is safe and effective as it goes to market.

• De-Risking The Transition From Vial To Drug-Device Combination Product

  When transitioning from a vial to a combination product system, the best approach is to have a holistic de-risk strategy with an intentional focus on the patient, the plan, and the product.

• Combining Gene Therapies, Carrier Systems, And Medical Devices

  Drug delivery is one of the most significant obstacles to advancing gene therapies. Examine the opportunities for success in combining novel medical devices to improve delivery of gene therapies.

• Your Approach To USP <382> For Your Drug Product Packaging

  The USP requirements for elastomeric components of container closure systems used for parenteral products are changing. Explore the implications for vial, syringe, and cartridge container closure systems.

• Addressing Patient Access To Medicines With Interconnected Networks

  Providing access to a well-established manufacturing network removes the risk of multiple tech transfers and third parties needed to achieve scale.